Alnylam Pharmaceuticals, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2014 | $-4.85 | $-2.72 |
| FY2015 | $-3.45 | $-2.98 |
| FY2016 | $-4.79 | $-3.39 |
| FY2017 | $-5.42 | $-3.79 |
| FY2018 | $-7.57 | $-4.35 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2014 | $-4.85 | $-2.72 |
| FY2015 | $-3.45 | $-2.98 |
| FY2016 | $-4.79 | $-3.39 |
| FY2017 | $-5.42 | $-3.79 |
| FY2018 | $-7.57 | $-4.35 |